⌘K
t
Hikma Pharmaceuticals PLC submitted its Block Listing Six Monthly Return on 1 April 2025. For the period from 1 October 2024 to 31 March 2025, the company reported a balance of 311,430 unallotted Ordinary Shares of 10 pence under its 2018 Management Incentive Plan and 2014 Executive Incentive Plan, with 0 shares issued during this period.
| Date | 1 Apr 2025 |
| Time | 09:30:52 |
| Category | Capital structure |
| ID | 1230D |
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 1 April 2025
|
Name of applicant: |
Hikma Pharmaceuticals PLC |
|||
|
Name of schemes: |
Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") |
|||
|
Period of return |
From: |
1 October 2024 |
To: |
31 March 2025 |
|
Balance of unallotted securities under scheme(s) from previous return: |
311,430 Ordinary Shares of 10 pence |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 Ordinary Shares of 10 pence |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
0 Ordinary Shares of 10 pence |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
311,430 Ordinary Shares of 10 pence |
|||
|
Name of contact: |
Helen Middlemist |
|
Telephone number of contact: |
+44(0)20 7399 2760 |
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI: 549300BNS685UXH4JI75)